Medical Advocates

Kaposi's Sarcoma
  Main Page

New and Noteworthy      Videos
General Reports
Pathogenesis
Case Reports
Diagnosis/Diagnostics
Comorbidities
Clinical Management
National Studies

Children
MSM

HIV Oncology Main Page OI Main Page    Main New/Newsworthy Home Page

Last Update:  May 23, 2017
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy
     

May 2017
 

General Reports
   

          Journal Papers, Abstracts, and Commentaries

   

Kaposi sarcoma herpesvirus-associated disorders and related diseases.
Goncalves PH, Ziegelbauer J, Uldrick TS, Yarchoan R.

Curr Opin HIV AIDS
. 2016 Sep 22.
Abstract

FULL-TEXT ARTICLE
KSHV-Mediated Angiogenesis in Tumor Progression.
Purushothaman P, Uppal T, Sarkar R, Verma SC.
Viruses. 2016 Jul 20;8(7). pii: E198. Review
Paper

Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi's sarcoma skin lesions.
Desnoyer A, Dupin N, Assoumou L,. et al

Br J Dermatol
. 2016 May 13.
Abstract

Steroids are a risk factor for Kaposi sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection.
Fernández-Sánchez M, Iglesias MC, et al

AIDS
. 2015 Dec 3
Abstract

Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
Schulz TF, Cesarman E.

Curr Opin Viro
l
. 2015 Sep 29;14:116-128.
Abstract

FULL-TEXT ARTICLE
Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.
Davis DA, Naiman NE, Wang V, et al

PLoS Pathog
. 2015 Jul 28;11(7):e1005064.
Paper

FULL-TEXT ARTICLE
Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
Viollet C, Davis DA, Reczko M, et al
P
PLoS One
. 2015 May 5;10(5):e0126439.
Paper

Kaposi Sarcoma-Associated Herpesvirus-Associated Malignancies: Epidemiology, Pathogenesis, and Advances in Treatment.
Bhutani M, Polizzotto MN, Uldrick TS, Yarchoan R.
Semin Oncol. 2015 Apr;42(2):223-246.
Abstract

Stability of structured Kaposi sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization.
Majerciak V, Pripuzova N, Chan C,  et al
J Virol. 2015 Jan 7. pii: JVI.03721-14.
Abstract

The expression profiles of microRNAs in Kaposi's sarcoma.
Wu XJ, Pu XM, Zhao ZF, et al
Tumour Biol. 2014 Oct 1.
Abstract

Vascular endothelial growth factor A polymorphism and risk of Kaposi's sarcoma herpesvirus viremia in kidney allograft recipients.
Alkharsah KR, Alzahrani AJ, Obeid OE,  et al
Transpl Infect Dis. 2014 Aug 14.
Abstract

Kaposi's sarcoma in HIV-positive patients: the state of art in the HAART-era.
La Ferla L, Pinzone MR, Nunnari G,

Eur Rev Med Pharmacol Sci
. 2013 Sep;17(17):2354-65.
Abstract

Oral Kaposi's sarcoma: a review and update.
Fatahzadeh M, Schwartz RA.
Int J Dermatol. 2013 Jun;52(6):666-72. 
Abstract

Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated human immunodeficiency virus infection.
Unemori PA, Leslie KS, Hunt PW,  et al

AIDS
.
2013 Feb 21.
Abstract

Microscopic diversity in oral Kaposi sarcoma.
Bunn BK, Carvalho Mde V, Louw M,  et al

Oral Surg Oral Med Oral Pathol Oral Radiol
2013 Feb;115(2):241-8
Abstract

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.
Lacombe JM, Boue F, Grabar S,  et al

AIDS
. 2012 Nov 28.
Abstract

Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
Santag S, Jäger W, Karsten CB,  et al

Oncogene
. 2012 Sep 10.
Abstract

miRNAs and usRNAs Discovered in Kaposi's Sarcoma-associated Herpesvirus Virions.
Lin X, Li X, Liang D, Lan K.

J Virol
. 2012 Sep 12.
Abstract

Lymphatic Reprogramming by Kaposi Sarcoma Herpes Virus Promotes the Oncogenic Activity of the Virus-Encoded G-protein Coupled Receptor.
Aguilar B, Choi I, Choi D,  et al  
Cancer Res. 2012 Aug 31
Abstract

Cancer angiogenesis induced by Kaposi's sarcoma-associated herpesvirus is mediated by EZH2.
He M, Zhang W, Bakken T, et al

Cancer Res
. 2012 May 16
Abstract

Does Kaposi's sarcoma predict multicentric Castleman disease in the presence of generalized lymphadenopathy?
Alkaied H, Harris K, Elsayegh D, et al
Med Oncol. 2011 Apr 7
Abstract

Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.
Uldrick TS, Whitby D.

Cancer Lett
. 2011 Mar 3.
Abstract

Risk Factors Influencing Antibody Responses to Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Antigens in Patients Under Antiretroviral Therapy.
Guadalupe M, Pollock BH, Westbrook S,  et al

J Acquir Immune Defic Syndr
. 2010 Nov 16.
Abstract

Is Kaposi's sarcoma occurring at higher CD4 cell counts over the course of the HIV
epidemic?
Crum-Cianflone NF, Hullsiek KH, Ganesan A,
et al
AIDS
. 2010 Sep 4.
Abstract
 

Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors.
Barillari G, Franzese O, Comandini A, et al
.
Oncol Rep. 2010 Jul;24(1):219-23.
Abstract

FULL-TEXT ARTICLE
The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.
Günther T, Grundhoff A.

PLoS Pathog
. 2010 Jun 3;6(6):e1000935
Paper
 

Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells.
Delgado T, Carroll PA, Punjabi AS,
et al
Proc Natl Acad Sci U S A
. 2010 Jun 8;107(23):10696-701
Abstract

Unique histologic variants of cutaneous Kaposi sarcoma.
O'Donnell PJ, Pantanowitz L, Grayson W.
 
Am J Dermatopathol
. 2010 May;32(3):244-50.
Abstract

Unique Histologic Variants of Cutaneous Kaposi Sarcoma.
O'Donnell PJ, Pantanowitz L, Grayson W.

Am J Dermatopathol
. 2010 Jan 14.
Abstract


Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells.
Delgado T, Carroll PA, Punjabi AS,
et al
Proc Natl Acad Sci U S A
. 2010 Jun 8;107(23):10696-701
Abstract
 

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon beta (IFN-{beta}) expression by competing with IFN regulatory factor-3 for binding to IFN-{beta} promoter.
Cloutier N, Flamand L.

B J Biol Chem
. 2010 Jan 4.
Abstract
 
 
Pathogenesis
 

          Journal Papers, Abstracts, and Commentaries

 
Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Fukumoto H, Kanno T, Hasegawa H, Katano H.
Front Microbiol. 2011;2:175.
Paper

FULL TEXT ARTICLE
Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution inflammatory syndrome-related Kaposi sarcoma.
Feller L, Lemmer J.
Infect Agent Cancer. 2008 Jan 21;3(1):1
Paper
 

FULL TEXT PDF ARTICLE
KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development.
Pyakurel P, Pak F, Mwakigonja AR
Infect Agent Cancer. 2007 Feb 2;2(1):4
Paper
 
Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation.
Bruno B, Sorasio R, Barozzi P, et al  
Eur J Haematol. 2006 Apr;76(4):342-7.
Abstract
 
KSHV infection and the pathogenesis of Kaposi's sarcoma
Ganem D.
Annu Rev Pathol. 2006;1:273-96.
Abstract
 

Diagnosis/Diagnostics
   

          Journal Papers, Abstracts, and Commentaries

 
Disseminated Kaposi's Sarcoma-A Missed Diagnosis.
Armstrong MB, Thurber J.

J Emerg Med
. 2014 Sep 22
Abstract

FULL-TEXT ARTICLE
Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcoma.
Kainerstorfer JM, Polizzotto MN, Uldrick TS,  et al

PLoS One
. 2013 Dec 27;8(12):e83887.
Paper

PET/CT imaging of HIV-negative Kaposi's sarcoma.
Sager S, Engin B, Kutlubay Z,  etal
Ir J Med Sci. 2013 Mar 25.
Abstract

False-Negative Results of Endoscopic Biopsy in the Diagnosis of Gastrointestinal Kaposi's Sarcoma in HIV-Infected Patients.
Nagata N, Sekine K, Igari T,  et al
Patholog Res Int. 2012;2012:854
Abstract

AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants?
Solivetti FM, Elia F, Latini A,  et al

J Exp Clin Cancer Res
. 2011 Apr 13;30(1):40
Abstract

Diagnostic pitfalls of HIV-associated Kaposi's sarcoma
Vanousová D, Jilich D, Machala L, et al
Klin Onkol. 2010;23(5):285-92.
Abstract

Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA.
Mbisa GL, Miley W, Gamache CJ,  et al

J Immunol Methods
. 2010 Apr 30;356(1-2):39-46.
Abstract

 

Comorbidities
       

          Journal Papers, Abstracts, and Commentaries
 
 
Co-infections and Pathogenesis of KSHV-Associated Malignancies.
Thakker S, Verma SC.

Front Microbiol
. 2016 Feb 15;7:151
.
Abstract

Malaria may influence the transmission of Kaposi sarcoma associated herpesvirus in endemic areas.
Nascimento MC.

Acquir Immune Defic Syndr
. 2014 Sep 1;67(1):e41-3
Abstract

Bone Marrow Findings in HIV-Positive Patients With Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Venkataraman G, Uldrick TS, Aleman K,  et al
Am J Clin Pathol. 2013 May;139(5):651-661
Abstract

FULL-TEXT ARTICLE
Kaposi Sarcoma Incidence and Survival Among HIV-Infected Homosexual Men After HIV Seroconversion.
Lodi S, Guiguet M, Costagliola D,
et al  
J Natl Cancer Ins
t
. 2010 May 4. |
Paper


Videos
       

Kaposi's Sarcoma Makes an Unwelcome Return
 


HIV Oncology Main Page OI Main Page     Main New/Newsworthy Home Page


 

Kaposi's Sarcoma

 

 

 

 

 

A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.
Uldrick TS, Gonçalves PH, Wyvill KM,
Oncologist
. 2017 May;22(5):505-e49.